Art

J-GLOBAL ID：201302248655345104   Reference number：13A1019482

Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia

最近発症した統合失調症患者の脳脊髄液における可溶性スーパーオキシドジスムターゼ-1(SOD1)の著明な減少

Author (15)： COUGHLIN J M (Johns HopkinsUniversity School of Medicine, MD, USA) ,  ISHIZUKA K (Johns HopkinsUniversity School of Medicine, MD, USA) ,  KANO S I (Johns HopkinsUniversity School of Medicine, MD, USA) ,  EDWARDS J A (Johns HopkinsUniversity School of Medicine, MD, USA) ,  SEIFUDDIN F T (Johns HopkinsUniversity School of Medicine, MD, USA) ,  SHIMANO M A (Johns HopkinsUniversity School of Medicine, MD, USA) ,  DALEY E L (Johns HopkinsUniversity School of Medicine, MD, USA) ,  ZANDI P P (Johns HopkinsUniversity School of Medicine, MD, USA) ,  ZANDI P P (Bloomberg School of Public Health, MD, USA) ,  LEWEKE F M (Univ. of Heidelberg, Mannheim, DEU) ,  CASCELLA N G (Johns HopkinsUniversity School of Medicine, MD, USA) ,  POMPER M G (Johns HopkinsUniversity School of Medicine, MD, USA) ,  YOLKEN R H (Johns HopkinsUniversity School of Medicine, MD, USA) ,  YOLKEN R H (Stanley Medical Res. Inst., MD, USA) ,  SAWA A (Johns HopkinsUniversity School of Medicine, MD, USA)
Material： Molecular Psychiatry
Volume： 18  Issue： 1  Page： 10-11  Publication year： Jan. 2013 
JST Material Number： A1362A  ISSN： 1359-4184  Document type： Article
Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Terms in the title (6)： 発症 ,  統合失調症患者 ,  脳脊髄液 ,  可溶性 ,  スーパーオキシドジスムターゼ ,  SOD1